A British vaccine against the Coronavirus seems to be according to a study, safe and stimulate the immune system. The resources of the University of Oxford and the British pharmaceutical company AstraZeneca triggers two responses of the immune system: It promotes both the formation of specific antibodies as well as T-cells, both for immune defense is important.
the results of the British medical journal “The Lancet reported on Monday”. First results were already announced last week. The UK has already ordered 100 million doses of the Vaccine. The first Experiments with 1077 healthy individuals were classified as promising. The vaccine generated according to the researchers, only slight side effects such as fatigue and headaches.
In addition, on Monday in “The Lancet” published a study by the results of a Phase 2 were published-the study of the Chinese company “CanSino”, the vaccine was tested in 508 study participants. This means called forth, therefore, the majority of participants, significant immune responses without severe side effects.
F. A. Z.-Newsletter “Coronavirus”
The whole world is talking about the Coronavirus. All the news and analysis about the spread and control of pandemic on a daily basis in your E-Mail Inbox.
Please take notice of our privacy.
just last week, the biotechnology company “Moderna had reported” in cooperation with the American “National Institute of Allergy and Infectious Diseases” (NIAID) in the “New England Journal of Medicine” a promising immune response in 45 test persons on the developed vaccine. However, it is still unclear whether the vaccines provide sufficient protection against infection, experts reported. In order to clarify this question, all three means are now in extensive Phase 3 studies, including in the United Kingdom, the United States, Brazil, and South Africa.
